Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM4FMZP)

Drug Name
N-Methylmesoporphyrin Drug Info
Synonyms
N-METHYLMESOPORPHYRIN; 3,3'-(8,13-diethyl-3,7,12,17,22-pentamethylporphyrin-2,18-diyl)dipropanoic acid; 3,3'-(8,13-diethyl-3,7,12,17,22-pentamethyl-22,24-dihydroporphyrin-2,18-diyl)dipropanoic acid; 21-Methylmesoporphyrin; AC1L9GRR; SCHEMBL505199; DB01911; J2.132.966E; 3,8,13,17,23-Pentamethyl-7,12-diethyl-21H,23H-porphyrin-2,18-dipropanoic acid; 3-[18-(2-carboxyethyl)-8,13-diethyl-3,7,12,17,22-pentamethyl-23H-porphyrin-2-yl]propanoic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
444708
CAS Number
CAS 142234-85-3
TTD Drug ID
DM4FMZP

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Ferrochelatase (FECH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cholic Acid DM7OKQV Cholelithiasis DC11 Approved [1]
Methyl aminolevulinate DMIUX3D Acne vulgaris ED80 Approved [2]
N-Methylmesoporphyrin Containing Copper DMKZL5H Discovery agent N.A. Investigative [1]
Lead acetate DML0GZ2 Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ferrochelatase (FECH) TTQ6VF4 HEMH_HUMAN Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res. 2009 May 15;15(10):3333-43.
3 Ferrochelatase, a novel target for photodynamic therapy of cancer. Oncol Rep. 1999 Nov-Dec;6(6):1439-42.